Diploma PLC (LON:DPLM - Get Free Report) insider Johnny Thomson sold 26,794 shares of the firm's stock in a transaction on Tuesday, November 19th. The stock was sold at an average price of GBX 4,536 ($57.56), for a total transaction of £1,215,375.84 ($1,542,355.13).
Diploma Stock Performance
LON DPLM traded down GBX 50 ($0.63) during trading hours on Wednesday, reaching GBX 4,124 ($52.34). The stock had a trading volume of 510,291 shares, compared to its average volume of 376,498. The company has a debt-to-equity ratio of 45.69, a quick ratio of 0.80 and a current ratio of 2.27. Diploma PLC has a 52-week low of GBX 3,200 ($40.61) and a 52-week high of GBX 4,653 ($59.05). The stock has a fifty day moving average of GBX 4,394.26 and a 200 day moving average of GBX 4,266.49. The stock has a market cap of £5.53 billion, a P/E ratio of 4,825.58, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75.
Diploma Increases Dividend
The business also recently declared a dividend, which will be paid on Friday, January 31st. Shareholders of record on Thursday, January 16th will be given a GBX 42 ($0.53) dividend. The ex-dividend date of this dividend is Thursday, January 16th. This represents a yield of 0.93%. This is a positive change from Diploma's previous dividend of $17.30. Diploma's dividend payout ratio (DPR) is currently 6,627.91%.
Analyst Upgrades and Downgrades
Separately, Shore Capital lowered shares of Diploma to a "hold" rating in a research report on Tuesday.
View Our Latest Analysis on Diploma
Diploma Company Profile
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Recommended Stories
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.